The team


Pathogenomix CTO and founder: Oystein F. Saebo - Chief Technology Officer, Director & Founder

Oystein F. Saebo - Chief Technology Officer, Director & Founder

Oystein brings deep computer science expertise to Pathogenomix and is a key inventor in creating and developing Pathogenomix's RipSeq product portfolio. He developed the Company's patented algorithms, large user base cloud solutions, and web-server deployment through server-side parallel processing, and is considered by many to be a leading authority in his line of work. Oystein is a co-founder of Pathogenomix. He has extensive international experience as a Principal Consultant and Systems Architect, and has over 20 years of algorithm design and development experience, working with Life Technologies / Thermo Fisher, Microsoft, Motorola, Grant Thornton and others.

Pathogenomix CMO and founder: Oyvind Kommedal, MD, PhD - Chief Medical Officer & Founder

Oyvind Kommedal, MD, PhD - Medical advisor

Oyvind is an internationally-recognized microbiologist whose unique insights about the intersection of medicine, technology, and business have guided Pathogenomix's vision and product development. Oyvind is a co-founder of Pathogenomix and one of the key inventors of the RipSeq. As a medical doctor specializing in infectious diseases Oyvind has gathered over 10 years of experience in routine diagnostics and research. He is currently leading a brain abscess study using Sanger and Next Generation Sequencing combined with Pathogenomix RipSeq software. He has authored or co-authored articles in more than 10 scientific publications (including Journal of Clinical Microbiology and the Journal of Medical Microbiology) utilizing RipSeq.

Pathogenomix COO: May Kristin Roen - Chief Operations Officer & Director

May Kristin Roen - Chief Operations Officer & Director

May brings her extensive experience in scaling early-stage companies to Pathogenomix's management. As a survivor of a bacterial infection that nearly killed her in 1999, her passion for Pathogenomix's mission is personal as well as professional. May has served on the board of over 10 different companies and non-profit organizations, and has significant operational experience, and previously has reorganized staff, implemented new IT solutions, managed quality control, and hired and trained new personnel. May also co-founded 12 Entrepreneurs, a non-profit exchange organization, to bring Silicon Valley and European entrepreneurs together, and ran business development for a government-backed regional technical incubator.

Pathogenomix Director: Ivan O'Sullivan

Ivan O'Sullivan - Director

Ivan is a software investor with a focus on SaaS services. He has more than 20 years of sales, marketing, and business development experience. Most recently Ivan was an executive at Defense.Net, acquired by F5 Networks; Digital Reef, acquired by Transperfect and Metalogix, acquired by Permira. Prior to Metalogix, he was SVP at StreamBase Systems (acquired by Tibco), Earlier in his career Ivan served as president of Elron Software (acquired by Zix Corp.) and North American president of Clearswift. He also held executive roles at Signiant (secure file sharing) and ON Technology Corp., (acquired by Symantec). Ivan holds a B.A. First Class Honors in business studies from London's Thames Polytechnic.

Pathogenomix Chairman: Chris Risley

Chris Risley - Chairman

Chris is an early stage investor who has led 8 Venture Capital backed companies resulting in one IPO, five acquired by Public Companies, and two acquired by Private Companies. Acquirers included: IBM, F5, Tibco, and Symantec. In addition, he spent 10 years as an Operating Partner at Bessemer Venture Partners. Prior to joining the Software Industry he spent 2 years as Advisor to the Chairman of British Aerospace. He holds a BA Magna Cum Laude from Cornell University and did the PMD program at Harvard Graduate School of Business.


Pathogenomix Advisor: Tim Hunkapiller, Advisor, Industry Expertise

Tim Hunkapiller, Advisor, Industry Expertise

Dr. Hunkapiller received his Ph.D. from the California Institute of Technology in Molecular Biology, and most recently has held a Research Assistant Professor appointment in the Department of Molecular Biotechnology at the University of Washington. Dr. Hunkapiller's research focus has included molecular immunology, evolution, computational genetics, comparative genomics and he is an expert on the genetics, genomic organization and functional diversity of the immune system. He has also been involved in bioinformatics, algorithm and database development, and experimental process optimization, for 20 years. While at Caltech, Dr. Hunkapiller originated the model for the automated, fluorescent DNA sequencer. The manifestation of this idea in products such as the ABI 3700tm and the MD Megabasetm sequencers catalyzed and enabled the completion of the first drafts of the Human Genome. He continues to work with Applied Biosystems on improving the throughput and quality of data from these instruments and their associated chemistry. Dr. Hunkapiller also developed the first operational special-purpose computer hardware to accelerate the analysis of biological sequence information. This work led to the development of the world's fastest sequence/profile comparison engine, the Paracel Genematchertm. This instrument is in place at major pharmaceutical, biotechnology and genomics companies that work in the target discovery and validation process. His group is currently working to integrate the signal processing power of the Genematcher with new high-throughput MS technologies aimed at the emerging proteomics arena. Dr. Hunkapiller has served as an advisor to a number of biotechnology companies as well as technology companies servicing the biotechnology and pharmaceutical industry. These efforts range from helping with SNP association studies for target discovery in breast cancer to the application of novel computer technologies in intelligently searching very large, unstructured text sources to improve intellectual property analysis.

Pathogenomix Advisor: Cathy Petti, MD, Advisor, Healthcare Industry and Innovation

Cathy Petti, MD, Advisor, Healthcare Industry and Innovation

Dr. Petti is a physician executive with expertise in leveraging advanced technologies to improve population, global, and individual health. She is Chief Health Officer at AncestryHealth, and founder/CEO of HealthSpring Global, Inc. - a boutique consulting firm for investors, biotech companies, and other health-minded stakeholders. Previously, she has held senior management positions as Global Head of Medical, Clinical and Scientific Affairs at Novartis Diagnostics, Chief Medical Officer at TriCore Reference Laboratories and Medical Director for ARUP Laboratories. With over 60 peer-reviewed publications, Dr. Petti is a leader in diagnostics, information health and global health, and sought-after speaker at international conferences. She holds an AB from Harvard University and MD from Duke University. Dr. Petti is dual board certified in infectious diseases and medical microbiology.

Pathogenomix Advisor: Camilla Huse Bondesson - Advisor, European markets

Camilla Huse Bondesson - Advisor, European markets

28 years of experience within Life Science through leading positions in sales, product management and marketing management. Former VP Marketing at Gyros AB, Marketing Director of Proteomics (AmershamPharmacia Biosciences, now GE Healtchare), International Product Manager at Biacore, General Manager at Behring Diagnostica AB and Product Manager at Althin Medical Norden AB. Partner of Conlega, since 2004. Exec. MBA from University of Stockholm, Sweden and Biomedical Scientist from Oslo School of Technology, Norway.